Showing posts with label cardiovascular. Show all posts
Showing posts with label cardiovascular. Show all posts

Tuesday, 14 May 2013

The most advanced bioartificial heart


The French company Carmat has been authorized to begin implementing its new human artificial heart, considered one of the most advanced to date. Although only some pilot tests have been carried out so far, the new artificial organ will be used for the first time in four hospitals in Belgium, Poland, Slovenia and Saudi Arabia.

This model is considered the latest generation of artificial heart, and although there are many advantages that have been observed in the tests, it is also true that there is little experience with their use. Unlike mechanical artificial hearts, which consist of a pump that is connected to the heart or implanted in the chest to help or replace a failing heart (without removing it), bioartificial hearts are designed to completely replace the original organ.

Una imagen del nuevo dispositivo.| Carmat
New bioartificial heart (copyright Carmat)

The device has a price of 200,000 euros and a battery life of about 14 hours. Moreover is manufactured with a series of materials that reduce the risk of thrombi to the patient, resulting in less need for anticoagulant therapy. Although it is early to assess what the outcome will be, the Carmat heart presents already some advantages compared to its predecessors: it is a smaller model (it weights just one kg) and it comes with a SW that controls it efficiently (the artificial heart regulates itself very well and knows how much blood is necessary to pump at all times).

In a joint statement, cardiac surgeons of the four hospitals have declared that "terminal heart failure is a major public health problem that crosses borders. This artificial heart is a true innovation for the medical community. We are eager to sart early implementations and analyze its potential benefits for our patients". When talking about this artificial heart, we are probably talking about the future treatment of heart failure.

Monday, 1 October 2012

Medical device destroys itself leaving no trace in the body

Imagine an electronic device that releases the drug in the area where it is needed, measure your vital signs, treats a surgical wound and once done it has done its job it melts away ... All this without leaving a trace, as if it had never been in the body. A new class of devices grouped under the name of "transient electronics" is about to start a medical revolution. The first step was just taken by a group of engineers at Tufts University, in the United States, who successfully tested one of these biodegradable devices. The experiment was done with mice that were implanted with a device designed to deliver drugs and treat an infection. Not only did the treatment work, but also it barely left remmants of its presence in the organism three weeks later. With only a few tens of nanometers thick, the new circuits are easily dissolved in either water or other body fluids without causing damage.

In the same line, Abbot lab has recently introduced a new "stent", a new type of coronary implant which is also absorved when is no longer useful. It has a less sophisticated technology than that of the electronic devices, but it works similarily. Stents are a mesh-like tube of thin metal wire which are placed inside the artery to keep them open and facilitate blood flow after a heart attack has occurred. Stents have been placed permanently for years. The absorbable one, made ​​of a material used in sutures, allowes the vessel to dilate and contract in a more natural way, as your body needs it. For example when you are running and need more blood flow. At the end of ist lifetime, the stent is complety disolved and the blood vessel remains open without any other extra support.

Sources:



Sunday, 4 March 2012

The engine of life

As hard as it is to find nowadays anything that can last more than just a few years, our heart is there to prove that nature is capable of creating the most amazing and reliable things. The muscle that never rests, pumping and beating to keep every part of our body oxygenated, starting as soon as 22 days after we are conceived, just until the day we leave this world.  It beats more than 30 millon times per year and more than 2000 million times during a whole life in average. With each heart beat, it pumps 80ml of blood, making 8000l a day, the power enough to push a car over 32kms. And all this in a muscle with the size of a fist.

CT Scan of a human heart
Heart keeps representing a challenge to medicine, as cardiovascular disease is still the leading cause of death in the world, even above cancer or traffic accidents. An estimated 17 million people die of CVDs, particularly heart attacks and strokes, every year. Many of this deaths are related to blocked arteries problems, and today I would like to present two promising technological advances to fight heart disease.

The first is a new application in transmyocardial revascularization (TMR) laser technology that may offer an alternative method of treatment to patients with severe heart disease who are not candidates for coronary bypass surgery or balloon angioplasty. A normal heart depends primarily on the coronary arteries to deliver its blood supply from the left ventricle cavity, the pumping chamber of the heart. In patients with heart disease, the coronary arteries are blocked preventing normal blood flow to the heart muscle. However, they still have a large supply of oxygenated blood in their left ventricular cavity. For a subset of patients who are not candidates for traditional cardiac surgery, which bypasses blocked arteries, surgeons have to create new pathways for the blood flow. TMR uses laser energy to create these pathways through a series of 1mm channels from the outer surface of the heart through the heart muscle into the left ventricular cavity, allowing for an increased blood flow directly from this "blood-filled" chamber to the oxygen-starved areas of the heart muscle.

The second is related to something that has already been discussed in the blog: nanotechnology. Concretely, targeted nanoparticles callled nanoburrs that can reach damaged vascular tissue and may be used to deliver drugs that help clear arteries. This new particles have been designed by MIT and Harvard researchers with the aim of treating cardiovascular disease. The nanoburrs are coated with tiny protein fragments that allow them to stick to damaged arterial walls. Once stuck, they can release drugs such paclitaxel, which inhibits cell division and helps prevent growth of scar tissue that can clog arteries. Moreover, drugs are delivered over a longer period of time, and can be injected intravenously, preventing patients from enduring repeated and surgically invasive injections directly into the area that requires treatment.

In the next posts we will see what is going on with pacemakers, apart from other curiosities about the heart. In the meantime, take well care of your heart by doing regular exercise, cutting down on cigarettes and eating healthier. Surely it will make the difference.